- Home
- VOYA vs HALO Comparison
VOYA vs HALO Comparison
Compare VOYA & HALO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VOYA
- HALO
- Stock Information
- Founded
- VOYA 1975
- HALO 1998
- Country
- VOYA United States
- HALO United States
- Employees
- VOYA N/A
- HALO N/A
- Industry
- VOYA Life Insurance
- HALO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- VOYA Finance
- HALO Health Care
- Exchange
- VOYA Nasdaq
- HALO Nasdaq
- Market Cap
- VOYA 6.7B
- HALO 7.3B
- IPO Year
- VOYA 2013
- HALO N/A
- Fundamental
- Price
- VOYA $71.95
- HALO $57.75
- Analyst Decision
- VOYA Buy
- HALO Buy
- Analyst Count
- VOYA 12
- HALO 9
- Target Price
- VOYA $82.55
- HALO $62.78
- AVG Volume (30 Days)
- VOYA 1.0M
- HALO 1.1M
- Earning Date
- VOYA 02-04-2025
- HALO 02-18-2025
- Dividend Yield
- VOYA 2.50%
- HALO N/A
- EPS Growth
- VOYA 13.84
- HALO 63.33
- EPS
- VOYA 6.17
- HALO 3.43
- Revenue
- VOYA $8,050,000,000.00
- HALO $1,015,324,000.00
- Revenue This Year
- VOYA N/A
- HALO $23.48
- Revenue Next Year
- VOYA $5.31
- HALO $18.16
- P/E Ratio
- VOYA $11.92
- HALO $16.84
- Revenue Growth
- VOYA 9.55
- HALO 22.44
- 52 Week Low
- VOYA $64.10
- HALO $37.73
- 52 Week High
- VOYA $84.30
- HALO $65.53
- Technical
- Relative Strength Index (RSI)
- VOYA 49.06
- HALO 62.93
- Support Level
- VOYA $72.56
- HALO $56.07
- Resistance Level
- VOYA $76.02
- HALO $60.67
- Average True Range (ATR)
- VOYA 2.16
- HALO 1.43
- MACD
- VOYA 0.14
- HALO -0.22
- Stochastic Oscillator
- VOYA 62.41
- HALO 48.86
About VOYA Voya Financial Inc.
Voya Financial Inc is a financial services company, which, through its subsidiaries, provides various investment, insurance, and retirement solutions to individual and institutional clients in the United States. Its products and services include tax savings plans, individual retirement accounts, group life insurance plans, and employee benefits products, among others. The company tailors each of its products to the needs of its customer base. It operates its business through three principal lines: Wealth Solutions, Investment Management, and Health Solutions The Wealth segment generates roughly half of the company's revenue.
About HALO Halozyme Therapeutics Inc.
Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with unmet medical needs, with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.